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Abstract
Aims/hypothesis Low birthweight in infants born at term is
related to the presence of the metabolic syndrome as an
adult. Individuals born preterm invariably have low birth-
weights and may develop the metabolic syndrome as well.
Although high BP, glucose intolerance and insulin resis-
tance have been documented, dyslipidaemia has never been
reported in individuals born preterm.
Methods In three groups of young adults [29 participants
from the POPS (Project On Premature and Small for
Gestational Age Infants) cohort born preterm appropriate for
gestational age (POPS-AGA), 28 participants from the POPS
cohort born preterm small for gestational age (POPS-SGA)
and 30 individuals born at term with normal birthweight
(CON)] we investigated fasting lipids as well as postprandial
responses during a mixed meal test. The relationship between
fasting and postprandial measurements and insulin sensitivity,
measured by the hyperinsulinaemic clamp, was investigated.
Results Preterm participants had higher BP than CON
individuals. Postprandial triacylglycerol levels were increased
in POPS-SGA men. POPS-SGA individuals were hyper-
insulinaemic during the mixed meal test.
Conclusions/interpretation The mixed meal test provides
additional information on cardiovascular risk factors.
Postprandial triacylglycerol levels are increased in POPS-
SGAmen. Postprandial hyperinsulinaemia is found in POPS-
SGA individuals.
Keywords Dyslipidaemia . Insulin sensitivity .
Mixed meal test . Prematurity
Abbreviations
ATP III Adult Treatment Panel III of the Expert
Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol
in Adults
BIA biometrical impedance analysis
CON control individuals born at term with
normal birthweight
MMT mixed meal test
POPS Project on Premature and Small for
Gestational Age Infants
POPS-AGA POPS adult born preterm appropriate
for gestational age
POPS-SGA POPS adult born preterm small for
gestational
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Introduction
In infants born at term, size at birth is related to the presence
of the metabolic syndrome [1] throughout adulthood [2–4].
In preterms, size at birth is also reduced and it is becoming
clear that preterm infants may be predisposed to the same
risks of developing the metabolic syndrome as infants with
a low birthweight at term. Insulin resistance has been found
in preterm-born prepubertal children [5] and young adults
[6]. Glucose intolerance and increased BP are already
present in young adulthood, but dyslipidaemia is not found
[6, 7].
In the present study the different components of the
metabolic syndrome, according to the Adult Treatment Panel
III of the Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults (ATP III)
definition, were investigated in young adults born preterm.
Because metabolic abnormalities may only become apparent
during the postprandial phase, lipid and glucose metabolism
were studied after a standardised mixed meal. Furthermore,
the hyperinsulinaemic–euglycaemic clamp technique was
used to study insulin sensitivity in relation to components of
the metabolic syndrome.
Young adults from the Project on Premature and Small for
Gestational Age Infants (POPS) born prematurely appropriate
for gestational age (POPS-AGA), young adults born prema-
turely small for gestational age (POPS-SGA) and term-born
controls with normal birthweight (CON) were compared.
It was hypothesised that prematurity, especially when
accompanied by a low birthweight for gestational age, pre-
disposes for altered lipid metabolism, which can be iden-
tified in the postprandial state.
Methods
Participants Participants were recruited from the POPS
cohort [8]. The POPS cohort comprises 94% of all Dutch
neonates (n=1,338) who were born alive in 1983 with a
gestational age of below 32 weeks and/or with a birthweight
<1,500 g. Address information of the participants and
families was available from the POPS database. Information
on disabilities was also available from the database. Disabled
individuals were excluded and not approached for this study.
Individuals were approached by telephone. Subsequently, an
information letter was sent. After 3 weeks individuals were
approached again by telephone.
From the POPS cohort we selected 47 individuals born
prematurely with an appropriate birthweight for gestational
age (birthweight standard deviation score [SDS] between 0
and +2 SDS: POPS-AGA) who had been treated in our
Neonatal Intensive Care Unit during the neonatal period.
Six individuals (13%) could not be traced, five individuals
(11%) were not eligible because of pregnancy and serious
disease and four individuals (9%) refused to participate.
Thirty POPS-AGA individuals (64%), 15 men and 15
women, were selected after they agreed to participate.
Characteristics at birth are shown in Table 1. Of the POPS-
AGA group one woman was excluded from the analysis
because of serious obesity (BMI 34.6 kg/m2).
From the POPS cohort we selected 42 individuals born
prematurely small for gestational age (birthweight SDS
below −2 SDS: POPS-SGA). These participants had been
treated in the neonatal period in different centres. One year
before the start of our study, 22 of these individuals had
participated in a study on renal function. Three individuals
(7%) could not be traced, ten individuals (24%) refused to
participate. Twenty-eight individuals (67%), 13 men and 15
women, were selected after they agreed to participate.
Originally, the definition of SGA in the POPS-SGA group
was birthweight SDS below −2 SDS. Because the high
refusal rate led to small group size we changed the definition
to the group of children within the cohort with the lowest
birthweight SDS. Fourteen SGA participants had a birth-
weight SDS lower than −2 SDS. The range of birthweight
SDS between the SGA and AGA group did not overlap.
Characteristics at birth are shown in Table 1.
The control group (CON) was recruited by advertise-
ment in the VU University medical faculty. The first 15
men and 15 women, born in 1983, who volunteered for the
study were selected. From taking the history we gathered
that they were born at term (37–42 weeks) with a birthweight
appropriate for gestational age.
Overall, most women (75%) used oral contraceptives.
Tests were performed throughout the menstrual cycle, as it
was not possible to schedule appointments in the early
follicular phase because of logistic reasons.
Study protocol Participants were investigated on two
separate days. During the first visit, a physical examination,
blood sampling to investigate the presence of the metabolic
syndrome and the hyperinsulinaemic–euglycaemic clamp
were performed. During the second visit, 2–6 weeks later, a
standardised mixed meal test (MMT) was performed.
Physical examination Participants arrived at the examination
room after an overnight fast. Measurement of the participant’s
weight and height were performed using an electronic scale
and stadiometer (SECA, Hanover, MD, USA). Weight was
measured to the nearest 0.1 kg, height the nearest 0.1 cm.
BMI was calculated as weight/height squared and expressed
as BMI SDS.
Waist circumference was measured at the level of the
umbilicus after full expiration while the individual was
standing upright, with feet together and arms hanging freely
at the sides, and hip circumference at the level of the greater
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trochanter, both with the use of a flexible tape measuring to
0.1 cm accuracy.
Fat mass and the corresponding fat-free mass were
estimated by biometrical impedance analysis (AKERN BIA
101/S; RJL Systems, Detroit, MI, USA).
BP was obtained with an automatic BP device (Dinamap;
Critikon, Norderstedt, Germany). Three measurements were
performed on the non-dominant arm with the individual in a
supine position after 15 min of rest, using an appropriate size
cuff for arm diameter. Mean values were used in statistical
analysis.
Metabolic syndrome components The metabolic syndrome
was defined according to the ATP III criteria [9]. Using
these criteria, the metabolic syndrome is identified by the
presence of three or more of these components: central obe-
sity (waist circumference ≥102 cm [men], >88 cm [women]);
raised fasting blood triacylglycerol (TG) (≥1.7 mmol/l);
reduced HDL-cholesterol (<1.0 [men] or <1.3 [women]
mmol/l); high BP (systolic ≥130 and/or diastolic ≥85 mmHg);
and increased fasting glucose levels (≥6.1 mmol/l).
Assays Fasting HDL-cholesterol and TG (HDL-cholesterol:
HDL-C Plus, TG: GPO-PAP; Roche, Mannheim, Germany)
were measured. Blood glucose was measured immediately
by the glucose oxidase method using a Yellow Springs Instru-
ment Glucose Analyzer (Yellow Springs, OH, USA).
Mixed meal test The MMT was performed 2–6 weeks after
the clamp study. The participants were investigated after an
overnight fast. An i.v. cannula was placed into the antecubital
vein for blood sampling. A standardised 400 ml liquid meal
(Fresubin Energy; Fresenius Kabi, Friedberg, Germany) with
an added 65 ml of unclotted cream was served that contained
76.7 g carbohydrates, 54.7 g fat and 29.3 g proteins.
After an overnight fast from 00:00 hours the previous
evening, each participant arrived at 08:30 hours at the test
room. An i.v. cannula was placed in an antecubital vein for
blood sampling. Fasting blood samples were drawn at −15
and 0 min for measurement of TG, HDL-cholesterol, NEFA,
glucose and insulin concentrations.
Thereafter participants were asked to drink the liquid
meal within 10 min. Blood collections for the measurement
of NEFA (enzymatic colorimetric test, NEFA-C; WAKO
Chemicals, Neuss, Germany) and TG levels were performed
at 60, 120, 180, 240 and 300 min. Blood collections for the
measurement of glucose (hexokinase method; Roche) and
insulin (immunometric assay; Bayer Diagnostics, Mijdrecht,
the Netherlands) levels were performed at 30, 60, 90, 120,
150, 180, 210, 240, 270 and 300 min.
Hyperinsulinaemic–euglycaemic clamp After an overnight
fast, a hyperinsulinaemic–euglycaemic clamp was performed
to determine insulin sensitivity by peripheral glucose uptake
as described by DeFronzo et al. [10]. Insulin (Velosulin; Novo
Nordisk, Bagsvaerd, Denmark) was infused at a rate of
60 mU kg−1 h−1 after a priming dose of 6 mU/kg. Hepatic
glucose production is known to be suppressed in non-diabetic
individuals by this infusion rate. The blood glucose level was
measured every 5 min (2300 STATplus C; Yellow Springs).
Blood glucose levels were clamped to a level of 5 mmol/l.
During the last hour every 15 min blood was drawn to
determine plasma insulin concentrations. Euglycaemia
(5 mmol/l) was maintained with 20% (wt/vol.) D-glucose
infusion. Under steady-state conditions of euglycaemia, the
rate of exogenous glucose infusion is equal to the rate of
insulin-stimulated glucose disposal. Insulin sensitivity was
calculated from the glucose infusion rate (mmol/minute)
between 60 and 120 min of the euglycaemic clamp, divided
by body weight and expressed as an M value (glucose
disposal, mmol kg−1 min−1) and an Mi value (glucose
disposal, mmol kg−1 min−1 [pmol/l]−1).
Statistical analysis For statistical analysis the SPSS pack-
age for Windows version 15 was used (SPSS, Chicago, IL,
USA). Results in Tables 1, 2 and 3 are expressed as means
±SD. Differences between the groups and relationships
with other factors were tested by linear regression analysis.
Differences between groups during the MMTwere analysed
longitudinally using linear mixed models where time was
treated as a categorical variable. With this strategy we were
able to analyse the differences between the groups at the
Table 1 Clinical characteristics of the POPS-AGA, POPS-SGA and CON groups at birth
CON POPS-AGA POPS-SGA p valuea
Sex (M/F) 15 M/15 F 15 M/14 F 13 M/15 F
GA (weeks) 40.0 28.9±1.4 30.7±1.1 <0.0001
Birthweight (g) 3,562±465 1536±300 934±146 <0.0001
Birthweight SDSb 0.11±1.0 1.11±0.27 −2.0±0.34 <0.0001
Means±SD
GA, gestational age
a Differences between any of the three groups analysed by ANOVA
bBirthweight SDS according to Niklasson et al. [23]
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different time-points in one model. A p value <0.05 was
considered to be statistically significant, based on two-sided
testing.
Ethical considerations The local ethics committee ap-
proved the study. All individuals gave written informed
consent to participate.
Results
Clinical characteristics of the groups All participants were
born in 1983. POPS-SGA individuals were shorter in com-
parison with POPS-AGA individuals (p=0.04) and CON
individuals (p=0.003) (Table 2).
Metabolic syndrome components Systolic BP was higher in
POPS-AGA (p<0.0001) and POPS-SGA (p=0.01) individ-
uals than in CON individuals. No differences were observed
between POPS-AGA and POPS-SGA participants (p=0.12).
Diastolic BP was higher in POPS-AGA (p=0.001) and
POPS-SGA (p=0.007) participants than in CON individu-
als. No differences were observed between POPS-AGA and
POPS-SGA participants (p=0.48) (Table 3).
MMT:TG levels A significant interaction was observed for
TG levels with group and sex (p≤0.003 at all time-points
from 120 min) (Fig. 1).
TG levels in POPS-SGA men were higher at 120 min
(p=0.01), 180 min (p<0.0001), 240 min (p<0.0001) and
300 min (p=0.003) than in CON men. POPS-SGA men had
higher TG levels than POPS-SGA women at 120 min (p=
0.001), 180 min (p<0.0001), 240 min (p<0.0001) and
300 min (p=0.003).
Among women, no differences were observed between
any of the groups.
Table 3 Components of the metabolic syndrome (ATP-III) of the POPS-AGA, POPS-SGA and CON groups during the first visit
CON POPS-AGA POPS-SGA p valuea
Sex (M/F) M F M F M F
Fasting glucose (mmol/l) 5.2±0.7 4.8±0.3 5.1±0.3 4.9±0.4 5.3±0.5 5.0±0.3 0.16
HDL-cholesterol (mmol/l) 1.4±0.3 1.6±0.3 1.4±0.2 1.8±0.5 1.4±0.3 1.7±0.4 0.69
TG (mmol/l) 0.9±0.4 1.0±0.4 1.0±0.5 0.8±0.3 1.1±0.5 0.8±0.3 0.94
WC (cm) 77.3±5.6 69.7±5.3 79.3±9.6 69.2±4.3 77.7±6.7 69.7±8.5 0.88
Systolic BP (mmHg) 120±10 116±9 139±15 125±12 130±11 124±14 <0.0001
Diastolic BP (mmHg) 64±5 66±8 73±8 72±5 68±8 73±10 0.002
Results expressed as means±SD
M, male; F, female; WC, waist circumference
a Differences between any of the three groups analysed by ANOVA
Table 2 Clinical characteristics of the POPS-AGA, POPS-SGA and CON groups at the time of the study
CON POPS-AGA POPS-SGA CON POPS-AGA POPS-SGA p valuea
Sex (M/F) M M M F F F
Age (years) 21.7±0.3 22.1±0.4 22.2±0.3 21.50.3 21.9±0.4 22.2±0.3 <0.0001
Height (cm) 185.9±4.8 183.1±8.9 178.9±6.7 171.6±3.8 169.6±7.9 162.3±5.1 0.003
Weight (kg) 76.2±8.2 77.0±16.8 70.3±8.5 63.3±6.5 61.2±9.7 57.9±9.2 0.12
BMI (kg/m2) 22.0±2.0 22.8±3.4 22.0±3.0 21.5±2.2 21.2±2.1 21.9±2.9 0.94
WC (cm) 77.3±5.6 79.3±9.6 77.7±6.7 69.7±5.3 69.2±4.3 69.7±8.5 0.88
Fat mass (kg)b 17.2±4.6 17.9±9.4 15.7±5.5 19.5±4.5 18.5±5.6 18.1±5.3 0.69
Fat percentagec 22.2±4.0 21.8±7.1 21.5±5.0 30.4±4.0 29.7±4.6 30.9±4.6 0.81
Fat-free mass (kg)d 59.0±4.7 59.2±7.7 55.1±3.0 43.9±2.7 42.7±4.5 39.5±4.6 0.10
M value (mmol kg−1 min−1) 0.078±0.020 0.057±0.016 0.058±0.021 0.065±0.023 0.051±0.021 0.053±0.012 0.001
Mi value (mmol kg−1
min−1 [pmol/l]−1)
0.0015±0.0006 0.0010±0.0004 0.0009±0.0004 0.0013±0.0007 0.0010±0.0004 0.0008±0.0003 <0.0001
Results expressed as means±SD
WC, waist circumference
a Differences between any of the three groups analysed by ANOVA
b Fat mass=weight of body fat derived from BIA measurement
c Fat percentage=percentage fat mass derived from BIA measurement
d Fat-free mass=weight of body fat-free mass derived from BIA measurement
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MMT:NEFA levels No differences in postprandial NEFA
levels were observed between the three groups (Fig. 1).
MMT:glucose levels No differences in postprandial glucose
levels were observed between the three groups (Fig. 2).
MMT:insulin levels Insulin levels were higher in POPS-
SGA participants compared with CON individuals at 30 min
(p=0.002), 60 min (p=0.015), 90 min (p=0.005), 120 min
(p=0.001), 150 min (p=0.015), 180 min (p=0.007),
210 min (p<0.0001) and 240 min (p=0.02) (Fig. 2). There
Fig. 1 TG and NEFA levels dur-
ing MMT in men (a, c) and
women (b, d) of the CON
(squares), POPS-AGA (circles)
and POPS-SGA (inverted trian-
gles) groups
Fig. 2 Glucose and insulin lev-
els during MMT in men (a, c)
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was no difference in insulin levels between CON and
POPS-AGA participants.
Insulin sensitivity Insulin sensitivity expressed as an Mi
value was lower in POPS-AGA (p=0.01) and POPS-SGA
(p<0.0001) participants than in CON individuals (Table 2).
Linear regression analysis adjusted for group showed a
significant relationship between TG levels and insulin
sensitivity at −15 min (p=0.015), 0 min (p=0.007),
60 min (p=0.031) and 300 min (p=0.019) during the
MMT. The relationship between TG levels and insulin
sensitivity was not different between men and women.
Discussion
The metabolic syndrome is a group of cardiovascular risk
factors including central obesity, dyslipidaemia, hyperten-
sion and raised fasting plasma glucose levels. The devel-
opment of the metabolic syndrome has been shown to be
more prevalent in adults born with low birthweight at term
than in control individuals [2, 3]. In individuals born
preterm, increased BP, glucose intolerance and insulin
resistance have been found [6, 7] but dyslipidaemia was
not reported.
As in the previous studies, we did not observe differ-
ences in fasting lipid levels between the three groups.
However, early signs of metabolic derangement may be
more easily detected in the postprandial state. Our study
shows that POPS-SGA men, especially, have increased TG
levels in the postprandial state.
As in previous reports [11] we found a relationship
between insulin sensitivity and TG levels, in which we
observed no sex differences.
A weakness of this study is that not enough individuals
could be included according to the SGA definition of
birthweight less than −2 SDS. Instead, individuals from the
cohort with the lowest birthweight had to be selected.
Therefore the POPS-SGA group may reflect the effects of
both moderate and extreme intrauterine growth retardation,
which makes a comparison with the POPS-AGA partic-
ipants more difficult.
Postprandial hypertriacylglycerolaemia is considered to
be a part of the metabolic syndrome [12]. It has been shown
that postprandial TG levels are related to the development
of cardiovascular disease [13] and that these levels are
related to insulin resistance [11]. A gradual rise in TG
levels throughout the day with peak concentrations between
dinner and bedtime has been reported in individuals with
insulin resistance [12]. Potentiation of TG levels may occur
in our individuals as well, as we observed maximum
postprandial TG levels hours after ingestion of the meal. It
seems unlikely that the increased lipid levels that we found
are explained by genetic causes of dyslipidaemia because
HDL- and LDL-cholesterol were not different between
subgroups.
In women, we found consistently lower TG levels
throughout the MMT compared with men. A problem of
our study is that, because of logistic reasons, the clamp
study could not be performed during the follicular phase.
Furthermore, 75% of women used oral contraceptives, which
are known to influence the metabolic measurements. Previous
studies have shown that women have lower postprandial TG
levels [14], probably because of the presence of oestrogens
and progestagens [15–18].
The MMT has been used for the assessment of beta cell
function [19–21]. The oral load results in a postprandial
exposure of the pancreas to glucose, amino acids and
hormones that closely reflects the ability of the pancreas to
produce insulin under normal physiological conditions [19].
We found that postprandial insulin levels were increased in
POPS-SGA participants compared with CON individuals.
This finding is different from the results of the hyper-
insulinaemic clamp study that showed that both POPS-
AGA and POPS-SGA participants are more insulin resistant
than the CON group. This may be explained by earlier
findings suggesting that insulin sensitivity measurements as
determined by the clamp and hyperinsulinaemia may identify
different metabolic subgroups [22]. Increased insulin levels
may also represent compensatory beta cell activity in
reaction to insulin resistance and increase the risk of beta
cell decompensation and the subsequent development of
glucose intolerance and type 2 diabetes in the future.
In conclusion, additional cardiovascular risk markers have
been identified in individuals born preterm. POPS-SGA men
have increased postprandial TG levels that are related to the
degree of insulin resistance. POPS-SGA individuals have
increased postprandial insulin levels because of their insulin
resistance.
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